Diadema Partners »

Ovid Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $244k 188k 1.30

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Ovid Therapeutics

Takeda Pharmaceutical
Vanguard Group
Affinity Asset Advisors
Acadian Asset Management
Renaissance Technologies
Sio Capital Management
Driehaus Capital Management
Adage Capital Partners GP
Kennedy Capital Management
Ikarian Capital
Millennium Management
Assenagon Asset Management
Schonfeld Strategic Advisors
Marshall Wace
Wells Fargo & Company

View all funds holding Ovid Therapeutics